Psychiatric comorbidities and schizophrenia
- PMID: 19011234
- PMCID: PMC2659306
- DOI: 10.1093/schbul/sbn135
Psychiatric comorbidities and schizophrenia
Abstract
Psychiatric comorbidities are common among patients with schizophrenia. Substance abuse comorbidity predominates. Anxiety and depressive symptoms are also very common throughout the course of illness, with an estimated prevalence of 15% for panic disorder, 29% for posttraumatic stress disorder, and 23% for obsessive-compulsive disorder. It is estimated that comorbid depression occurs in 50% of patients, and perhaps (conservatively) 47% of patients also have a lifetime diagnosis of comorbid substance abuse. This article chronicles these associations, examining whether these comorbidities are "more than chance" and might represent (distinct) phenotypes of schizophrenia. Among the anxiety disorders, the evidence at present is most abundant for an association with obsessive-compulsive disorder. Additional studies in newly diagnosed antipsychotic-naive patients and their first-degree relatives and searches for genetic and environmental risk factors are needed to replicate preliminary findings and further investigate these associations.
References
-
- Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT., Jr A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001;58:165–171. - PubMed
-
- Green AI, Canuso C, Brenner MJ, Wijcik JD. Detection and management of comorbidity in schizophrenia. Psychiatr Clin N Am. 2003;26:115–139. - PubMed
-
- Siris S, Bench C. Depression and schizophrenia. In: Hirsch S, Weinberger D, editors. Schizophrenia. 2nd ed. Oxford, UK: Blackwell; 2003. pp. 142–167.
-
- Moller HJ. Drug treatment of depressive symptoms in schizophrenia. Clin Schizophr Relat Psychoses. 2007;1:328–340.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical